Literature DB >> 10852142

Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies.

S K Inouye1.   

Abstract

Delirium is a common, costly, and potentially devastating condition for hospitalized older patients. Delirium is a multifactorial syndrome, involving the inter-relationship between patient vulnerability, or predisposing factors at admission, and noxious insults or precipitating factors during hospitalization. Through a series of studies, we first identified significant predisposing factors for delirium, including vision impairment, severe illness, cognitive impairment, and dehydration. Subsequently, significant precipitating factors were identified, including physical restraint use, malnutrition, adding more than three drugs, bladder catheter use, and any iatrogenic event. Through targeting preventive strategies towards six identified risk factors in a controlled clinical trial, we were successful in the primary prevention of delirium. In 852 subjects, the incidence of delirium was significantly reduced in the intervention group compared with usual care (9.9% vs 15.0%, matched odds ratio: 0.60; 95% confidence interval: 0.39-0.92). The total number of days and episodes of delirium were also significantly reduced in the intervention group. Based on this work, evidence-based recommendations for delirium prevention are proposed. While not all cases of delirium will be preventable with this approach, unifying medical and epidemiological approaches to delirium represents a key advance essential to reducing the high morbidity and mortality associated with delirium in the older population.

Entities:  

Mesh:

Year:  2000        PMID: 10852142     DOI: 10.3109/07853890009011770

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  43 in total

Review 1.  Assessing confused patients.

Authors:  M H Johnson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

Review 2.  Delirium: an important (but often unrecognized) clinical syndrome.

Authors:  Terry Rabinowitz
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 3.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

4.  A Descriptive Report of Early Mobilization for Critically Ill Ventilated Patients with Cancer.

Authors:  Amanda Weeks; Claudine Campbell; Prabalini Rajendram; Weiji Shi; Louis Voigt
Journal:  Rehabil Oncol       Date:  2017-07

5.  Physician Information Needs in Managing Delirium.

Authors:  Teresa Taft; Scott D Nelsen; Stacey Slager; Charlene Weir
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

6.  Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis.

Authors:  Tammy T Hshieh; Jirong Yue; Esther Oh; Margaret Puelle; Sarah Dowal; Thomas Travison; Sharon K Inouye
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

7.  Melatonin and Sleep in Preventing Hospitalized Delirium: A Randomized Clinical Trial.

Authors:  Stuti J Jaiswal; Thomas J McCarthy; Nathan E Wineinger; Dae Y Kang; Janet Song; Solana Garcia; Christoffel J van Niekerk; Cathy Y Lu; Melissa Loeks; Robert L Owens
Journal:  Am J Med       Date:  2018-05-03       Impact factor: 4.965

8.  American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2014-12-12       Impact factor: 5.562

Review 9.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

10.  Association between intraoperative blood transfusions and early postoperative delirium in older adults.

Authors:  Matthias Behrends; Glen DePalma; Laura Sands; Jacqueline Leung
Journal:  J Am Geriatr Soc       Date:  2013-03       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.